IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 165 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $710,915 | -25.5% | 109,036 | -0.5% | 0.00% | -25.0% |
| Q1 2024 | $954,816 | -26.8% | 109,623 | -3.9% | 0.00% | -20.0% |
| Q4 2023 | $1,305,235 | +51.4% | 114,094 | +27.5% | 0.01% | +25.0% |
| Q3 2023 | $862,000 | -70.6% | 89,500 | -59.3% | 0.00% | -73.3% |
| Q4 2019 | $2,928,000 | +45.2% | 220,000 | +101.5% | 0.02% | +50.0% |
| Q3 2018 | $2,016,000 | -12.4% | 109,200 | -9.3% | 0.01% | -16.7% |
| Q2 2018 | $2,301,000 | +37.9% | 120,370 | +11.3% | 0.01% | +33.3% |
| Q1 2018 | $1,669,000 | -10.8% | 108,195 | -13.4% | 0.01% | 0.0% |
| Q4 2017 | $1,872,000 | -1.8% | 124,909 | +3.3% | 0.01% | -10.0% |
| Q3 2017 | $1,906,000 | -56.2% | 120,888 | -47.6% | 0.01% | -16.7% |
| Q2 2017 | $4,356,000 | +568.1% | 230,750 | +503.7% | 0.01% | +200.0% |
| Q1 2017 | $652,000 | – | 38,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |